original article
January 26, 2012 | G. von Minckwitz and Others
Bevacizumab added to neoadjuvant combination chemotherapy increased the rate of pathological complete response among patients with HER2-negative early-stage breast cancer. The effect was greatest in patients with the poorest prognosis, those with so-called triple-negative tumors.
- CME
- Comments
editorial
January 26, 2012 | A.J. Montero and C. Vogel
original article
January 26, 2012 | J.D. Berry
and Others
and Others
Data from more than 250,000 men and women in 18 cohort studies were used to calculate the lifetime risk of cardiovascular events, stratified according to risk-factor burden, with adjustment for the competing risk of death from noncardiovascular causes.
Specialties
Cardiology
perspective 
January 25, 2012 | H.J. Aaron
and A.B. Frakt
(DOI: 10.1056/NEJMp1200448)
and A.B. Frakt
(DOI: 10.1056/NEJMp1200448)
- Comments
perspective
January 25, 2012 | J.R. Antos
(DOI: 10.1056/NEJMp1200446)
(DOI: 10.1056/NEJMp1200446)
- Comments
Featured Multimedia
original articles
G. von Minckwitz and Others
- CME
- Comments
H.D. Bear and Others
J.D. Berry and Others
M.J. Ombrello and Others
Published Online: January 11, 2012
images in clinical medicine
H. Saeed and S. Massarweh
- Free Full Text
case records of the massachusetts
general hospital
general hospital
E. Melendez and Others
Perspective
A. Alhassani, A. Chandra, and M.E. Chernew
Published Online: December 21, 2011
- Free Full Text
- Audio Interview
- Comments
D.B. Kramer, A.E. Buxton, and P.J. Zimetbaum
- Free Full Text
D.K. Jones
Published Online: January 11, 2012
- Free Full Text
- Comments
- No corrections published in this issue.
perspective
January 25, 2012 | P.A. Cohen
(DOI: 10.1056/NEJMp1113325)
(DOI: 10.1056/NEJMp1113325)
perspective
January 25, 2012 | H.J. Aaron and A.B. Frakt
(DOI: 10.1056/NEJMp1200448)
(DOI: 10.1056/NEJMp1200448)
perspective
January 25, 2012 | J.R. Antos
(DOI: 10.1056/NEJMp1200446)
(DOI: 10.1056/NEJMp1200446)
